The ARIC study of an elderly population of >66 years old, with a median follow-up of 6.3 years, showed that cTnI improves mortality and CVD risk stratification in older adults beyond traditional risk factors, and improves model discrimination better than cTnT for certain outcomes, CV mortality and heart failure (69). The gene discussed is TNNI3; the disease is heart failure.